H-1B sponsorship profile: Emugen Therapeutics LLC. Across U.S. Department of Labor LCA disclosures, Emugen Therapeutics LLC filed 2 Labor Condition Applications covering 2 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (2 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Emugen Therapeutics LLC’s H-1B petitions range from $90,688 at the low end to $97,968 at the high end, with a petition-weighted average of $94,328. That range reflects the mix of occupations the company sponsors, led by Financial Analyst (1 petitions at $90,688 avg), followed by Data Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Emugen Therapeutics LLC is headquartered in Woburn, MA under NAICS code 541714, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Emugen Therapeutics LLC ranks. By H-1B petition volume, Emugen Therapeutics LLC is #48,558 of 119,880 employers nationally and #2,213 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.